Arkolith/Insider Trading/ORIC/Form 4

You Angie

DirectorOric Pharmaceuticals, Inc. (ORIC) · full profile →Form 4 · filed Jun 23, 2025
Net Buying
Open-Market Buys
$263K
Open-Market Sells
$0
Net Open-Market Flow
$263K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2025Buy(P)1K$9.43$13K28K
Jun 20, 2025Buy(P)27K$9.39$250K27K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-018014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML